IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy

Annals of Neurology

Volumn 57, Issue 2, 2005, Pages 180-187

  Lombardi, Raffaella ^a,b   Erne, Beat ^a   Lauria, Giuseppe ^b   Pareyson, Davide ^b   Borgna, Monica ^b   Morbin, Michela ^b   Arnold, Andreas ^a   Czaplinski, Adam ^a   Fuhr, Peter ^a   Schaeren Wiemers, Nicole ^a   Steck, Andreas J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; IMMUNOGLOBULIN M; MYELIN ASSOCIATED GLYCOPROTEIN;

ARTICLE; CELL DENSITY; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DEMYELINATION; HUMAN; IMMUNOGLOBULIN DEPOSITION; NERVE DEGENERATION; NEUROPATHY; NONMYELINATED NERVE; POLYRADICULONEUROPATHY; PREVALENCE; PRIORITY JOURNAL; SCHWANN CELL; SKIN BIOPSY; SKIN NERVE;

BIOPSY; HUMANS; IMMUNOGLOBULIN M; MICROSCOPY, CONFOCAL; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE FIBERS, MYELINATED; POLYRADICULONEUROPATHY; SKIN;

EID: 19944433269     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20364     Document Type: Article

References (46)

1. Mata M, Kahn SN, Fink DJ. A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy. Arch Neurol 1988;45:693-697.
2. Martini R, Schachner M. Molecular bases of myelin formation as revealed by investigations on mice deficient in glia cell surface molecules. Glia 1997;19:298-310.
3. Li C, Trapp B, Ludwin S, et al. Myelin associated glycoprotein modulates glial-axon contact in vivo. J Neurosci Res 1998;51:210-217.
4. Arroyo EJ, Scherer SS. On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000;113:1-18.
5. Garbay B, Heape AM, Sargueil F, Cassagne C. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 2000;61:267-304.
6. Lopate G, Kornberg AJ, Yue J, et al. Anti-myelin associated glycoprotein antibodies: variability in patterns of IgM binding to peripheral nerve. J Neurol Sci 2001;188:67-72.
7. Lunn MPT, Crawford TO, Hughes RAC, et al. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing. Brain 2002;125:904-911.
8. Mendell JR, Sahenk Z, Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin associated glycoprotein antibody. Ann Neurol 1985;17:243-254.
9. Ellie E, Vital A, Steck AJ, et al. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 1996;243:34-43.
10. Meucci M, Baldini L, Cappellari A, et al. Anti-myelin-associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann Neurol 1999;46:119-122.
11. Steck AJ, Erne B, Gabriel J-M, Schaeren-Wiemers N. Paraproteinemic neuropathies. Brain Pathol 1999;9:361-368.
12. Eurelings M, Moons KGM, Notermans NC, et al. Neuropathy and IgM M-proteins (prognostic value of antibodies to MAG, SGPG, and sulfatide). Neurology 2001;56:228-233.
13. Kelly JJ Jr. The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies. Muscle Nerve 1990:13:1113-1117.
14. Trojaborg W, Hays AP, Van den Berg L, et al. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 1995;18:730-735.
15. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987;37:242-256.
16. Gabriel J-M, Erne B, Miescher GC, et al. Selective loss of myelin glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy. Brain 1996;119:775-787.
17. Gabriel J-M, Erne B, Bernasconi L, et al. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol 1998;95:540-546.
18. Hays AP, Lee SSL, Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 1988;18:231-244.
19. Stoll G, Schmidt B, Jander S, et al. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991;30:147-155.
20. Monaco S, Ferrari S, Bonetti B, et al. Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex. J Neuropathol Exp Neurol 1995;54:96-104.
21. Ferrari S, Morbin M, Nobile-Orazio E, et al. Antisulfatide polyneutopathy: antibody-mediated complement attack on peripheral myelin. Acta Neuropathol 1998;96:569-574.
22. Mead RJ, Singhrao SK, Neal JW, et al. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 2002;168:458-465.
23. Ritz M-F, Erne B, Ferracin F, et al. Anti-MAG IgM penetration myelinated fibers correlates with the extent of myelin widening. Muscle Nerve 1999;22:1030-1037.
24. Vital C, Vital A, Deminiere C, et al. Myelin modifications in 8 cases of peripheral neuropathy with Waldenstrom's macroglobulinemia and anti-MAG activity. Ultrastruct Pathol 1997;21:509-516.
25. Dalsgaard C-J, Rydh M, Haegerstrand A. Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistiy 1989;92:385-390.
26. Kennedy WR, Wendelschafer-Crabb G. The innervation of human epidermis. J Neurol Sci 1993;115:184-190.
27. McCarthy BG, Hsieh S-T, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855.
28. McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density. Normative reference range and diagnostic efficiency. Arch Neurol 1998;55:1513-1520.
29. Johansson O, Wang L, Hilliges M, Liang Y. Intraepidermal nerves in human skin: PGP 9.5 immunohistochemistry with special reference to the nerve density in skin from different body regions. J Peripher Nerv Syst 1999;4:43-52.
30. Lauria G. Innervation of human epidermis. A historical review. Ital J Neurol Sci 1999;20:63-70.
31. Burger D, Simon M, Peruisseau G, Steck AJ. The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein. J Neurochem 1990;54:1569-1575.
32. Gabriel JM, Erne B, Pareyson D, et al. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997;49:1635-1640.
33. Miescher G, Lutzelschwab R, Erne B, et al. Reciprocal expression of myelin-associated glycoprotein splice variants in the adult human peripheral and central nervous systems. Mol Brain Res 1997;52:299-306.
34. Vital A, Vital C, Julien J, et al. Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol (Berl) 1989;79:160-176.
35. Nobile-Orazio E, Manfredini E, Carpo M, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994;36:416-424.
36. Van den Berg, Hays AP, Nobile-Orazio E, et al. Anti-MAG and anti SGPG antibodies in neuropathy. Muscle Nerve 1996;19:637-643.
37. Chassande B, Leger JM, Younes-Chennoufi AB, et al. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve 1998;21:55-62.
38. Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999;22:800-822.
39. Monaco S, Bonetti B, Ferrari S, et al. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 1990;322:649-652.
40. Nolano M, Provitera V, Crisci C, et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol 2003;54:197-205.
41. Sollberger M, Erne B, Sansano S, et al. Characterization of human nerve basal lamina for their binding properties of anti-MAG antibodies. J Neurocytol 2002;31:5-14.
42. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin associated glycoprotein. Ann Neurol 1993;33:502-506.
43. Chiang MC, Lin YH, Pan CL, et al. Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 2002;59:1094-1098.
44. Pan CL, Tseng TJ, Lin YH, et al. Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations. Brain 2003;126:386-397.
45. Lauria G, Borgna M, Morbin M, et al. Tubule and neurofilament immunoreactivity in human hairy skin: markers for intra-epidermal nerve fibers. Muscle Nerve 2004;30:310-316.
46. Lauria G, Holland N, Hauer P, et al. Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neurol Sci 1999;164:172-178.